Log In
BCIQ
Print this Print this
 

Fabior, tazarotene

  Manage Alerts
Collapse Summary General Information
Company Allergan plc
DescriptionTopical foam formulation of tazarotene, a retinoid prodrug
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationAcne
Indication DetailsTreat acne vulgaris
Regulatory Designation
PartnerGlaxoSmithKline plc

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$50.1M

$50.1M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

08/18/2016

$50.1M

$50.1M

0

Get a free BioCentury trial today